Silver Spring, Maryland–(ENEWSPF)–September 30, 2013. The U.S. Food and Drug Administration today approved Brintellix (vortioxetine) to treat adults with major depressive disorder.
FDA Approves New Drug to Treat Major Depressive Disorder
More in Health and Fitness:
